GlassScriptPhysician profile
Stephen Thomas Frascone
NPI 1477597961
$2,072.99
in general payments reported to CMS, 2019-2025
21 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $116 · 2021: $474 · 2022: $54.66 · 2023: $65.34 · 2024: $119 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $461.00 | 2019 | |
| Pinnacle, INC | $430.53 | 2019 | |
| Treace Medical Concepts, INC. | $186.20 | 2021-2025 | |
| Organogenesis INC. | $178.54 | 2019-2021 | |
| Osteomed LLC | $116.98 | 2021 | |
| Kerecis Limited | $91.35 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $90.47 | 2019-2022 | |
| Horizon Therapeutics Plc | $66.24 | 2019-2023 | Krystexxa |
| Philips North America LLC | $66.03 | 2021 | |
| Stimwave Technologies Incorporated | $57.09 | 2020-2021 | |
| Stryker Corporation | $54.47 | 2020-2021 | |
| Sebela Pharmaceuticals INC. | $51.58 | 2019 | |
| Abbott Laboratories | $41.44 | 2023-2024 | Proclaim |
| Fidia Pharma USA INC. | $30.26 | 2023 | Triluron, Hymovis |
| Zimmer Biomet Holdings, INC. | $28.65 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $24.91 | 2020-2024 | Zetuvit Plus 10x10 P10 |
| Medtronic, INC. | $23.27 | 2025 | Inceptiv |
| Mimedx Group, INC. | $23.23 | 2024 | |
| Paragon 28, INC. | $21.37 | 2019 | |
| Amgen INC. | $14.77 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $14.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Frascone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.